CLINICAL TRIAL: MATERNAL DETERMINANTS OF NEONATAL GLUCAGON LIKE PEPTIDE 1

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这项研究的目的是在多大程度上孕妇的基因或她自己的血糖浓度影响胎儿产生的特定蛋白质（称为胰高血糖素样肽-1或GLP-1）。GLP-1被认为在成年型糖尿病的发展中起作用，发现胎儿中这种蛋白质的影响可能有助于我们更好地了解成人II型糖尿病。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to what extent a pregnant's mother's genes or her own blood sugar concentration influences a specific protein (named Glucagon-like Peptide-1 or GLP-1) the fetus makes. GLP-1 is thought to play a role in the development of adult-type diabetes later in life and discovering what influences this protein in a fetus may help us better understand adult type II diabetes.